SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants rally is being tied chiefly to its Robinhood listing, alongside community attention to reported banking and tokenized-deposit initiatives involving the project. Bulls point to broader institutional adoption and QNTs limited supply, while skeptics warn the move may be a short-lived news-driven pump.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Optimism that Metas Muse AI agent could drive greater CPU demand is underpinning AMDs rally, alongside broader AI-chip enthusiasm. Traders are split between riding the momentum and warning that valuation has outrun fundamentals, with some attributing the move to short-covering and FOMO.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is drawing attention ahead of its quarterly results, with traders focused on whether AI-driven memory demand, tight DRAM supply and stronger pricing will support results and guidance. Many expect continued upside, while others warn that expectations are elevated and debate a possible sell-the-news reaction, memory cyclicality and broader market pressures.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

A multiyear Anthropic cloud-computing agreement has put Akamais AI infrastructure opportunity in focus, but traders are debating whether the growth potential justifies the substantial buildout costs and possible dilution from warrants. Enthusiasm over the deal and the initial share surge has given way to profit-taking and concern about the stocks pullback.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondos BlackRock-powered tokenized portfolio launch is fueling renewed interest in its real-world asset tokenization story, alongside bullish breakout chatter as the token rallies. Traders are also debating whether that growth can benefit ONDO holders, since the token is currently viewed as primarily governance-focused and a fee switch remains uncertain.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars sharp selloff and fresh 52-week low are being tied to analyst concerns about limited visibility into future bookings, alongside uncertainty over solar policy and trade. Traders are divided between viewing the decline as an oversold buying opportunity and expecting further weakness; some attribute the move to short-selling or manipulation, without evidence.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductor ETF attention centers on the AI-driven chip rally and whether its momentum can continue. Bulls point to AI and data-center demand, while bears warn that high valuations, heavy infrastructure spending and rising yields could leave the sector vulnerable to a pullback.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibabas new Zhenwu V900 AI chip and data-center expansion plans have put its effort to build an integrated AI business in focus, with bulls seeing growth potential but questioning whether it will translate into returns. That optimism is being weighed against volatile trading and concerns over U.S. allegations that Alibaba and other Chinese firms extracted or distilled American AI models, heightening geopolitical and regulatory risk.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets sharp selloff and volatile trading have traders debating whether Metas Muse raises a real competitive threat to Googles AI and search business, alongside concerns about AI spending and macroeconomic pressure. Bulls call the decline overdone and point to Gemini 4 and Googles AI projects, while bears see growing competitive and regulatory risks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp share-price move is drawing speculation that ImmunityBio could pursue tokenized stock trading through Nant, which bullish traders believe might curb naked shorting; the idea remains unconfirmed, and some argue the focus distracts from Anktivas regulatory and commercial progress. Speculation about a possible Anktiva expansion in Turkey after Patrick Soon-Shiong met President Erdogan is adding to short-squeeze talk, while skeptics question whether the rally has a confirmed catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?

Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?

Harmony Biosciences (HRMY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Myriad Genetics, Inc. (Myriad Genetics or the Company) (NASDAQ: MYGN) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other...

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 10, 2026 Myriad Genetics reported Q2 2026 revenue of approximately $190.7 million against consensus of roughly $206-208...

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad Genetics, Inc. (Myriad or the Company) (NASDAQ: MYGN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses...

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)

On May 5, 2026, Myriad Genetics (NASDAQ: MYGN) reaffirmed adjusted EBITDA of $37 million to $49 million and adjusted gross margin of 68% to 69% for full-year 2026. Roughly three months later, the adjusted EBITDA range was suspended outright and MYGN shares dropped. If you held Myriad Genetics stock...

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics PR Newswire NEW YORK, Aug. 4, 2026 Myriad Genetics guided to...

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) PR Newswire NEW YORK, Aug. 3, 2026 On May 5...

Why Did RBLX, HTZ, MYGN Stocks Plunge To 52-Week Lows Last Week?

Equity

Investors became less willing to wait for companies’ long-term plans when those businesses continued to face problems delivering results in the short term. 


Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know

Myriad Genetics stock fell after hours after weak Q2 results, lower guidance and an operating loss.read more...

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

MYGN Myriad Genetics, Inc.